These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 29388060)

  • 21. Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons.
    Enestvedt CK; Perry KA; Kim C; McConnell PW; Diggs BS; Vernon A; O'Rourke RW; Luketich JD; Hunter JG; Jobe BA
    Dis Esophagus; 2010 Feb; 23(2):136-44. PubMed ID: 19515189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do we manage early rectal cancer? A national questionnaire survey among members of the ACPGBI after the preliminary results of the MRC CR07/NCIC CO16 randomized trial.
    Srinivasaiah N; Joseph B; Mackey P; Monson JR
    Colorectal Dis; 2008 May; 10(4):357-62. PubMed ID: 17764532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Rectal Cancer Without Radical Resection.
    Beets GL; Figueiredo NF; Beets-Tan RG
    Annu Rev Med; 2017 Jan; 68():169-182. PubMed ID: 27618750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
    São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
    Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
    Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
    Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
    Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
    Wang Y; Chen G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.
    Chadi SA; Berho M; Wexner SD
    Langenbecks Arch Surg; 2015 Aug; 400(6):661-73. PubMed ID: 26250144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data.
    Verrijssen AS; Guillem J; Perez R; Bujko K; Guedj N; Habr-Gama A; Houben R; Goudkade D; Melenhorst J; Buijsen J; Vanneste B; Grabsch HI; Bellezzo M; Paiva Fonseca G; Verhaegen F; Berbee M; Van Limbergen EJ
    Radiother Oncol; 2020 Mar; 144():37-45. PubMed ID: 31710942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opinions have changed on the management of rectal cancer with a complete clinical response to neoadjuvant chemoradiotherapy.
    São Julião GP; Smith FM; Macklin CP; George ML; Wynn GR
    Colorectal Dis; 2014 May; 16(5):392-4. PubMed ID: 24612274
    [No Abstract]   [Full Text] [Related]  

  • 31. Robotic transanal minimally invasive surgery for rectal cancer after clinical complete response to neoadjuvant chemoradiation.
    Ngu JC; Kuo LJ; Kung CH; Chen CL; Kuo CC; Chang SW; Chen CC
    Int J Med Robot; 2018 Oct; 14(5):e1948. PubMed ID: 30073747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of transanal total mesorectal excision in radical surgery for rectal cancer].
    He L; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):957-960. PubMed ID: 28836258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
    Hupkens BJP; Martens MH; Stoot JH; Berbee M; Melenhorst J; Beets-Tan RG; Beets GL; Breukink SO
    Dis Colon Rectum; 2017 Oct; 60(10):1032-1040. PubMed ID: 28891846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.
    Allaix ME; Arezzo A; Morino M
    Surg Endosc; 2016 Nov; 30(11):4841-4852. PubMed ID: 26902614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between surgeon characteristics and their preferences for guideline-concordant staging and treatment for rectal cancer.
    Charlton ME; Mattingly-Wells LR; Marcet JE; McMahon Waldschmidt BC; Cromwell JW
    Am J Surg; 2014 Nov; 208(5):817-823. PubMed ID: 24997492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradigm-shifting new evidence for treatment of rectal cancer.
    Fichera A; Allaix ME
    J Gastrointest Surg; 2014 Feb; 18(2):391-7. PubMed ID: 23888373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synchronous Locally Advanced Rectal Cancer with Clinical Complete Remission and Important Downstaging after Neoadjuvant Radiochemotherapy - Personalised Therapeutic Approach.
    Georgescu DE; Georgescu MT; Bobircă FT; Georgescu TF; Doran H; Pătraşcu T
    Chirurgia (Bucur); 2017; 112(6):726-733. PubMed ID: 29288615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.